Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting

NCT01474915 is registered in ClinicalTrials.gov with Sergio Bergese as lead sponsor.

NCT NCT01474915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01474915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting
Lead sponsor
Sergio Bergese
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2007
Completion date
April 30, 2013
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nausea, postoperative nausea and vomiting (ponv)